• Cencora
  •  Overview
  • Last Modified:
  • November 11, 2025
  • Company type:
  • Public
  • Industry:
  • Pharmaceutical
  • Verified:
  • No
  • No of Employees:
  • 10 001 - 50 000
  • Stock Code:
  • COR
  • Download
  • Signed Health Status Declaration Form
  • Turnover $50m + ?:
  • Yes
  • Headquarters:
  • Conshohocken, Pennsylvania,
  • Public Interest Score:
  • 750+

 

  • Cencora
  • General Information

Description

Cencora, formerly AmerisourceBergen, is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers, and pharmacies to improve product access and efficiency throughout the healthcare supply chain.

A leading global pharmaceutical solutions organization committed to improving the lives of people and animals everywhere.

Cencora was established in 2023, as a new name for the AmerisourceBergen Corporation. As thye help shape a new era of healthcare, building on their legacy of more than 100 years of progress and excellence in pharmaceutical sourcing and wholesale distribution.

More specifically, they distribute a comprehensive offering of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers located in the United States and select global markets;

Including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other customers.

Additionally, they furnish healthcare providers and pharmaceutical manufacturers with an assortment of related services, including data analytics, outcomes research, reimbursement and pharmaceutical consulting services (including regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance) niche premium logistics services, inventory management, pharmacy automation, pharmacy management, and packaging solutions.

Mark Durcan:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Werner Baumann:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Frank Clyburn:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Lon Greenberg:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Lorence Kim:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Robert Mauch:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Redonda Miller:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Dennis Nally:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Lauren Tyler:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Lori Ryerkerk:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

Subscribe / Login

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

  • Company Information
  • Company System Number:
  • 14790
  • Founded Year: 
  • 2001
  • Registration Number: 
  • 23-3079390
  • Country: 
  • United States of America
  • Stock Exchanges: 
    • New York Stock Exchange
  • Financial year end: 
  • September
  • No. of Countries operations: 
  • 50
  • Company Status: 
  • In Business
  • Industry Sub Category: 
  • Date listed on Stock Exchange: 

 

  • Contact Information
  • Business operation: 
  • Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care.
  • Primary office: 
  • 1 West First Avenue Conshohocken, PA 19428.

 

  • Additional Information
  • Listed?: 
  • Yes
  • Company secretary: 
  • Reporting currency: 
  • USD
  • ISIN number (12 digit): 
NYSE
US03073E1055
  • Authorised shares:
  • 600 000 000
  • Issued shares:
  • 294 822 962
  • No of shareholders:
  • 1001 and more shareholders
  • No of shareholders holding 20%:
  • 0 shareholders
  • Number of shares traded
  • Per Year:
  • Per Quarter:
  • Per Month:

 

Subscribe/ Login to view more details on Health Status 

Subscribe / Login

 

Material Subsidiaries/Associates


For a comprehensive list, please contact InsidEntity.

Credit Rating

NameLogoCountryHeadquartersRating
fitch ratingCredit LogoUnited States of AmericaNew YorkA-

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Mark D.

Non Executive
NationalityAmerican
65
RoleNED
QualificationB.S.CH.E, M.CH.E
Date Appointed: 01/01/2015
Duration:
11 years and 8 months
Independance: N
Profile
Name

Werner

Non Executive
NationalityGermany
63
RoleNED
QualificationEconomics
Date Appointed: 01/01/2023
Duration:
3 years and 8 months
Independance: Y
Profile
Name

Frank

Non Executive
NationalityUnited States of America
RoleNED
QualificationMBA
Date Appointed: 01/10/2024
Duration:
1 year and 11 months
Independance: Y
Profile
Name

Lon R.

Non Executive
NationalityAmerican
75
RoleNED
QualificationNot Available
Date Appointed: 01/01/2013
Duration:
13 years and 8 months
Independance: N
Profile
Name

Lorence H.

Non Executive
NationalityAmerican
67
RoleNED
QualificationMD Doctor, MBA Healthcare, AB Biochemical Sciences
Date Appointed: 01/01/2022
Duration:
4 years and 8 months
Independance: Y
Profile
Name

Robert P.

Executive
NationalityAmerican
2
RoleCEO
QualificationPh.D. in Pharmacy Administration
Date Appointed: 01/01/2024
Duration:
2 years and 8 months
Independance: Y
Profile
Name

Redonda

Non Executive
NationalityAmerican
59
RoleNED
QualificationNot Available
Date Appointed: 01/01/2023
Duration:
3 years and 8 months
Independance: Y
Profile
Name

Dennis M

Non Executive
NationalityAmerican
73
RoleNED
QualificationCPA
Date Appointed: 01/01/2020
Duration:
6 years and 8 months
Independance: Y
Profile
Name

Lauren

Non Executive
NationalityUnited States of America
RoleNED
QualificationMBA
Date Appointed: 01/01/2023
Duration:
3 years and 8 months
Independance: Y
Profile
Name

Lori

Non Executive
NationalityAmerican
RoleNED
QualificationNot Available
Date Appointed: 30/10/2025
Duration:
0 year and 10 months
Independance: Y
Profile

 

Directors Tenure

Name
Duration
Name

Mark D. Durcan

Duration11 years and 8 months
Profile
Name

Werner Baumann

Duration3 years and 8 months
Profile
Name

Frank Clyburn

Duration1 year and 11 months
Profile
Name

Lon R. Greenberg

Duration13 years and 8 months
Profile
Name

Lorence H. Kim

Duration4 years and 8 months
Profile
Name

Robert P. Mauch

Duration2 years and 8 months
Profile
Name

Redonda Miller

Duration3 years and 8 months
Profile
Name

Dennis M Nally

Duration6 years and 8 months
Profile
Name

Lauren Tyler

Duration3 years and 8 months
Profile
Name

Lori Ryerkerk

Duration0 year and 10 months
Profile

 

Director Experience

Name
Experience
Name

Mark

Experience Technology, Business Services, Software and IT
Profile
Name

Werner

Experience Financial Services, Business Services
Profile
Name

Frank

Experience Pharmaceutical
Profile
Name

Lon R.

Experience Energy, Business Services, Education
Profile
Name

Lorence H.

Experience Medical Equipment, Pharmaceutical, Banking
Profile
Name

Robert P.

Experience Business Services, Pharmaceutical
Profile
Name

Redonda

Experience Healthcare, Medical Equipment, Education
Profile
Name

Dennis M

Experience Financial Services
Profile
Name

Lauren

Experience Financial Services, Investment
Profile
Name

Lori

Experience Business Services
Profile

 

Company Auditors

Name
Date Appointed
Years
Name

Ernst & Young

Date Appointed01/01/1985
Year41 years and 8 months
Profile

 

Company Past Directors

Name
ED/NED
Role
Name

Ornella

ED/NEDNon Executive
RoleNED
Date Appointed: 01/01/2015
Date Resigned: 27/05/2025
Profile
Name

Richard W.

ED/NEDNon Executive
RoleNED
Date Appointed: 25/09/2008
Date Resigned: 22/01/2025
Profile
Name

Kathleen W.

ED/NEDNon Executive
RoleNED
Date Appointed: 01/01/2010
Date Resigned: 22/01/2025
Profile
Name

Steven H.

ED/NEDExecutive
RoleChairman
Date Appointed: 01/01/2016
Date Resigned: 01/10/2024
Profile

 

Company Committees

Name

Mark Duncan

Mainboard, Audit, Remuneration BD, EX
Profile
Name

Werner Baumann

Mainboard, Audit, Remuneration BD, AU, RE
Profile
Name

Frank Clyburn

Mainboard, Audit, Remuneration BD
Profile
Name

Lon R. Greenberg

Mainboard, Audit, Remuneration BD, RC, NG, EX
Profile
Name

Lorence H. Kim

Mainboard, Audit, Remuneration BD, RE, CI, EX
Profile
Name

Robert P. Mauch

Mainboard, Audit, Remuneration BD
Profile
Name

Redonda Miller

Mainboard, Audit, Remuneration BD, RC, NG, EX
Profile
Name

Dennis M Nally

Mainboard, Audit, Remuneration BD, AU, RE, EX
Profile
Name

Lauren Tyler

Mainboard, Audit, Remuneration BD, NG, OT
Profile
Name

Lori Ryerkerk

Mainboard, Audit, Remuneration BD
Profile

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT